Author:
Arai Sally,Klingemann Hans-G.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Mielcarek M, Sanmaier BM, Maloney DG, et al. Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.J Clin Immunol. 2002;22:70–74.
2. Klingemann HG, Grigg AP, Wilkie-Boyd K, et al. Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse.Blood. 1991;78:3306–3311.
3. Balkwill FR. Interferons.Lancet. 1989;1:1060–1063.
4. Kohn FR, Phillips GL, Klingemann H-G. Analysis of cytokineinduced TNF-α production by monocytes offers new therapeutic potential for bone marrow transplant (BMT) recipients [abstract].Blood. 1990;76(suppl 1):549.
5. Sone S, Utsugi T, Nii A, Ogura T. Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity.J Natl Cancer Inst. 1988; 80:425–431.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献